Trial
NCT04786093
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Non Small Cell Lung Cancer
Intervention
Stereotactic radiation therapy
Why stopped
Sponsor decision to halt funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-05